A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease (TED). A homology analysis of 11 patients with TED and 11 controls pinpointed ...

Luxturna, a treatment for LCA caused by mutations in the RPE65 gene, was the first gene therapy approved in the US in 2017 for a genetic disease. To the FDA ... another company developing treatments ...

With its lead program, Merida is targeting Graves’ disease, an autoimmune disorder that attacks the thyroid. The condition is characterized by autoantibodies binding to thyroid-stimulating hormone ...

Introduction: Graves´ disease (GD) is the predominant cause of hyperthyroidism. Treatment options include antithyroid drugs (ATD), surgery, and radioactive iodine ablation (RI). Although thyroid ...

Per draft FDA dry eye disease guidance, to be considered for regulatory approval in the United States, efficacy in dry eye disease may be demonstrated with two symptom trials and two sign trials.

Graves disease had a similar phenotype at presentation but a more severe clinical course when isolated than when part of autoimmune polyglandular syndrome. Despite similarities in biochemical and ...